{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:44:12Z","timestamp":1785825852907,"version":"3.56.0"},"reference-count":117,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13243","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:15:32Z","timestamp":1784092532000},"page":"1-15","source":"Crossref","is-referenced-by-count":0,"title":["Ubiquitin\u2011driven regulation of immune checkpoints in lung cancer: Mechanisms and therapeutic implications (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Lin","family":"Chai","sequence":"first","affiliation":[{"name":"Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Rong","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Guo","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Jin","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Pathophysiology, Department of Biochemistry and Molecular Biology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"key20260804085543_b1-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/OP-24-00862","article-title":"Evolving field of immunotherapy: Pioneering new paths in Small-cell lung cancer","volume":"21","author":"Hazim","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"20","key":"key20260804085543_b2-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41533-025-00417-x","article-title":"The interactions among factors associated with the risk of lung cancer among diabetes patients: A survival tree analysis","volume":"35","author":"Yau","year":"2025","journal-title":"NPJ Prim Care Respir Med"},{"key":"key20260804085543_b3-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.21037\/jtd.2018.03.15","article-title":"Updated statistics of lung and bronchus cancer in United States (2018)","volume":"10","author":"Boloker","year":"2018","journal-title":"J Thorac Dis"},{"key":"key20260804085543_b4-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5415\/apallergy.0000000000000146","article-title":"From tumor to tolerance: A comprehensive review of immune checkpoint inhibitors and immune-related adverse events","volume":"14","author":"Sutanto","year":"2024","journal-title":"Asia Pac Allergy"},{"key":"key20260804085543_b5-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"key20260804085543_b6-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J"},{"key":"key20260804085543_b7-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"key":"key20260804085543_b8-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1084\/jem.171.5.1393","article-title":"LAG-3, a novel lymphocyte activation gene closely related to CD4","volume":"171","author":"Triebel","year":"1990","journal-title":"J Exp Med"},{"key":"key20260804085543_b9-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/s1074-7613(03)00147-x","article-title":"B7S1, a novel B7 family member that negatively regulates T cell activation","volume":"18","author":"Prasad","year":"2003","journal-title":"Immunity"},{"key":"key20260804085543_b10-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"key20260804085543_b11-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"key":"key20260804085543_b12-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"key20260804085543_b13-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"key20260804085543_b14-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"3","key":"key20260804085543_b15-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-025-01202-1","article-title":"Post-translational modifications of immune checkpoints: Molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications","volume":"33","author":"Hsieh","year":"2026","journal-title":"J Biomed Sci"},{"issue":"200773","key":"key20260804085543_b16-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200773","article-title":"Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party","volume":"32","author":"Lu","year":"2024","journal-title":"Mol Ther Oncol"},{"issue":"3309","key":"key20260804085543_b17-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123309","article-title":"Potential of E3 ubiquitin ligases in cancer immunity: Opportunities and challenges","volume":"10","author":"Ye","year":"2021","journal-title":"Cells"},{"key":"key20260804085543_b18-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41580-024-00778-0","article-title":"Mechanisms and regulation of substrate degradation by the 26S proteasome","volume":"26","author":"Arkinson","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"368","key":"key20260804085543_b19-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06255-2","article-title":"The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"key20260804085543_b20-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41418-020-00703-w","article-title":"The ubiquitin system: From cell signalling to disease biology and new therapeutic opportunities","volume":"28","author":"Damgaard","year":"2021","journal-title":"Cell Death Differ"},{"key":"key20260804085543_b21-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrm.2016.91","article-title":"Structural insights into the catalysis and regulation of E3 ubiquitin ligases","volume":"17","author":"Buetow","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1620097","key":"key20260804085543_b22-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1620097","article-title":"Regulatory role of E3 ubiquitin ligases in multiple myeloma: From molecular mechanisms to therapeutic strategies","volume":"13","author":"Chen","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"key20260804085543_b23-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2024.12.015","article-title":"Ubiquitin-A structural perspective","volume":"85","author":"Agrata","year":"2025","journal-title":"Mol Cell"},{"issue":"148","key":"key20260804085543_b24-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: From mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260804085543_b25-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"108","key":"key20260804085543_b26-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260804085543_b27-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"key20260804085543_b28-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/PPO.0000000000000061","article-title":"Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation","volume":"20","author":"Sanmamed","year":"2014","journal-title":"Cancer J"},{"issue":"4835","key":"key20260804085543_b29-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat Commun"},{"issue":"115569","key":"key20260804085543_b30-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115569","article-title":"The therapeutic potential of PD-1\/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components","volume":"167","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"207","key":"key20260804085543_b31-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01900-0","article-title":"Acidosis-mediated increase in IFN-\u03b3-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors","volume":"22","author":"Knopf","year":"2023","journal-title":"Mol Cancer"},{"issue":"11894","key":"key20260804085543_b32-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92209-z","article-title":"Engineered PD-L1 co-expression in PD-1 knockout and MAGE-C2-targeting TCR-T cells augments the cytotoxic efficacy toward target cancer cells","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci Rep"},{"issue":"1235","key":"key20260804085543_b33-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031235","article-title":"Targeting the PD-1\/PD-L1 signaling pathway for cancer therapy: Focus on biomarkers","volume":"26","author":"Strati","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20260804085543_b34-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"key20260804085543_b35-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41556-020-0562-4","article-title":"Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy","volume":"22","author":"Gao","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"28","key":"key20260804085543_b36-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00418-x","article-title":"Targeting the ubiquitination\/deubiquitination process to regulate immune checkpoint pathways","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"e154754","key":"key20260804085543_b37-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154754","article-title":"Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling","volume":"133","author":"Ding","year":"2023","journal-title":"J Clin Invest"},{"key":"key20260804085543_b38-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112674118","article-title":"The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage","volume":"118","author":"De","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"key20260804085543_b39-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-022-00507-x","article-title":"MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Discov"},{"key":"key20260804085543_b40-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1074\/jbc.M110.203729","article-title":"SCCRO (DCUN1D1) promotes nuclear translocation and assembly of the neddylation E3 complex","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"key20260804085543_b41-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.yexcr.2018.12.001","article-title":"DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer","volume":"374","author":"Li","year":"2019","journal-title":"Exp Cell Res"},{"key":"key20260804085543_b42-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cac2.12460","article-title":"USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer","volume":"43","author":"Li","year":"2023","journal-title":"Cancer Commun (Lond)"},{"issue":"918314","key":"key20260804085543_b43-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918314","article-title":"Immune evasion and drug resistance mediated by USP22 in cancer: Novel targets and mechanisms","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"key20260804085543_b44-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"issue":"9","key":"key20260804085543_b45-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44466-7","article-title":"Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1","volume":"15","author":"Ren","year":"2024","journal-title":"Nat Commun"},{"issue":"e167728","key":"key20260804085543_b46-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167728","article-title":"CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion","volume":"133","author":"Wang","year":"2023","journal-title":"J Clin Invest"},{"key":"key20260804085543_b47-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1111\/cas.14529","article-title":"Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells","volume":"111","author":"Mao","year":"2020","journal-title":"Cancer Sci"},{"issue":"1051","key":"key20260804085543_b48-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04356-6","article-title":"USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1","volume":"12","author":"Pan","year":"2021","journal-title":"Cell Death Dis"},{"issue":"11795549241281932","key":"key20260804085543_b49-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1177\/11795549241281932","article-title":"Unraveling the mechanism of action of Ubiquitin-specific Protease 5 and its inhibitors in tumors","volume":"18","author":"Wang","year":"2024","journal-title":"Clin Med Insights Oncol"},{"issue":"275","key":"key20260804085543_b50-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02862-3","article-title":"E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells","volume":"42","author":"Liang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"113477","key":"key20260804085543_b51-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113477","article-title":"E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC","volume":"42","author":"Tang","year":"2023","journal-title":"Cell Rep"},{"issue":"e005116","key":"key20260804085543_b52-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005116","article-title":"FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer","volume":"10","author":"Liu","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"e002840","key":"key20260804085543_b53-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002840","article-title":"Tryptophan potentiates CD8(+) T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation","volume":"9","author":"Qin","year":"2021","journal-title":"J Immunother Cancer"},{"key":"key20260804085543_b54-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated macrophages in lung cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"issue":"4852","key":"key20260804085543_b55-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25032-5","article-title":"USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"issue":"9629","key":"key20260804085543_b56-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179629","article-title":"The ubiquitin system: An emerging therapeutic target for lung cancer","volume":"22","author":"Jin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20260804085543_b57-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"6692","key":"key20260804085543_b58-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"issue":"1432545","key":"key20260804085543_b59-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1432545","article-title":"The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies","volume":"15","author":"Ren","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20260804085543_b60-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.7150\/jca.77619","article-title":"Clinical implications of the interaction between PD-1\/PD-L1 and PI3K\/AKT\/mTOR pathway in progression and treatment of non-small cell lung cancer","volume":"13","author":"Quan","year":"2022","journal-title":"J Cancer"},{"issue":"4564","key":"key20260804085543_b61-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59621-5","article-title":"USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity","volume":"16","author":"Dai","year":"2025","journal-title":"Nat Commun"},{"issue":"1700","key":"key20260804085543_b62-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29401-6","article-title":"USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy","volume":"13","author":"Xiong","year":"2022","journal-title":"Nat Commun"},{"key":"key20260804085543_b63-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/1873-3468.12985","article-title":"E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer","volume":"592","author":"Wang","year":"2018","journal-title":"FEBS Lett"},{"issue":"e864","key":"key20260804085543_b64-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.864","article-title":"RNF182 induces p65 ubiquitination to affect PDL1 transcription and suppress immune evasion in lung adenocarcinoma","volume":"11","author":"Zeng","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"11787","key":"key20260804085543_b65-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92177-4","article-title":"Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma","volume":"15","author":"Sun","year":"2025","journal-title":"Sci Rep"},{"key":"key20260804085543_b66-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41590-023-01569-z","article-title":"LAG-3 as the third checkpoint inhibitor","volume":"24","author":"Aggarwal","year":"2023","journal-title":"Nat Immunol"},{"key":"key20260804085543_b67-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2567.2005.02145.x","article-title":"The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells","volume":"115","author":"Ma\u00e7on-Lema\u00eetre","year":"2005","journal-title":"Immunology"},{"key":"key20260804085543_b68-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"issue":"5282","key":"key20260804085543_b69-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105282","article-title":"Understanding LAG-3 Signaling","volume":"22","author":"Chocarro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20260804085543_b70-ETM-32-3-13243","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.161.8.4058","article-title":"CD3\/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3\/TCR signaling","volume":"161","author":"Hannier","year":"1998","journal-title":"J Immunol"},{"issue":"7513","key":"key20260804085543_b71-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51930-5","article-title":"Structural basis for mouse LAG3 interactions with the MHC class II molecule I-Ab","volume":"15","author":"Ming","year":"2024","journal-title":"Nat Commun"},{"key":"key20260804085543_b72-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.4049\/jimmunol.1002050","article-title":"MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis","volume":"186","author":"Hemon","year":"2011","journal-title":"J Immunol"},{"key":"key20260804085543_b73-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1158\/0008-5472.CAN-14-2956","article-title":"Aberrant expression of MHC class II in melanoma attracts inflammatory Tumor-specific CD4+ T-cells, which dampen CD8+ T-cell antitumor reactivity","volume":"75","author":"Donia","year":"2015","journal-title":"Cancer Res"},{"issue":"19","key":"key20260804085543_b74-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010019","article-title":"The role of YY1 in the regulation of LAG-3 expression in CD8 T cells and immune evasion in cancer: Therapeutic implications","volume":"17","author":"Merenstein","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20260804085543_b75-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/2326-6066.CIR-14-0150","article-title":"Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells","volume":"3","author":"Kouo","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"e115","key":"key20260804085543_b76-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.115","article-title":"Fibrinogen-like 1: A hepatokine linking liver physiology to hematology","volume":"8","author":"Personnaz","year":"2024","journal-title":"Hemasphere"},{"key":"key20260804085543_b77-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7150\/ijbs.56748","article-title":"The role of Fibrinogen-like proteins in cancer","volume":"17","author":"Yu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"key20260804085543_b78-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbrc.2015.07.078","article-title":"Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development","volume":"465","author":"Nayeb-Hashemi","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"213","key":"key20260804085543_b79-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03140-6","article-title":"FGL1: A novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A\/STAT3 transcription mechanism","volume":"43","author":"Liu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"eabc2728","key":"key20260804085543_b80-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc2728","article-title":"Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding","volume":"5","author":"Andrews","year":"2020","journal-title":"Sci Immunol"},{"issue":"1146934","key":"key20260804085543_b81-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1146934","article-title":"Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer","volume":"13","author":"Kim","year":"2023","journal-title":"Front Oncol"},{"key":"key20260804085543_b82-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1038\/sj.onc.1204781","article-title":"Beyond the RING: CBL proteins as multivalent adapters","volume":"20","author":"Tsygankov","year":"2001","journal-title":"Oncogene"},{"key":"key20260804085543_b83-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/18050","article-title":"Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase","volume":"398","author":"Meng","year":"1999","journal-title":"Nature"},{"key":"key20260804085543_b84-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.cell.2025.02.014","article-title":"Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs","volume":"188","author":"Jiang","year":"2025","journal-title":"Cell"},{"issue":"113362","key":"key20260804085543_b85-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113362","article-title":"FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation","volume":"42","author":"Tian","year":"2023","journal-title":"Cell Rep"},{"key":"key20260804085543_b86-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1158\/2767-9764.CRC-23-0468","article-title":"Epithelial expressed B7-H4 drives differential immunotherapy response in murine and human breast cancer","volume":"4","author":"Wescott","year":"2024","journal-title":"Cancer Res Commun"},{"key":"key20260804085543_b87-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"10388","DOI":"10.1073\/pnas.1434299100","article-title":"B7x: A widely expressed B7 family member that inhibits T cell activation","volume":"100","author":"Zang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20260804085543_b88-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7-H3 and B7-H4 expression in non-small-cell lung cancer","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"issue":"101007","key":"key20260804085543_b89-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101007","article-title":"B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas","volume":"54","author":"Qi","year":"2024","journal-title":"Neoplasia"},{"issue":"104008","key":"key20260804085543_b90-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.104008","article-title":"B7-H4, a promising target for immunotherapy","volume":"347","author":"Wang","year":"2020","journal-title":"Cell Immunol"},{"issue":"217020","key":"key20260804085543_b91-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217020","article-title":"The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7-H4 in lung adenocarcinoma harboring EGFR-activating mutants","volume":"596","author":"Lu","year":"2024","journal-title":"Cancer Lett"},{"key":"key20260804085543_b92-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced Squamous-cell Non-Small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"key20260804085543_b93-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-Positive Non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"key20260804085543_b94-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): A phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet"},{"key":"key20260804085543_b95-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1200\/JCO.22.00975","article-title":"Durvalumab with or without tremelimumab in combination with chemotherapy as First-Line therapy for metastatic Non-Small-Cell lung cancer: The phase III POSEIDON study","volume":"41","author":"Johnson","year":"2023","journal-title":"J Clin Oncol"},{"issue":"e192535","key":"key20260804085543_b96-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw Open"},{"key":"key20260804085543_b97-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","article-title":"Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"key20260804085543_b98-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nature13566","article-title":"Crystal structure of the human COP9 signalosome","volume":"512","author":"Lingaraju","year":"2014","journal-title":"Nature"},{"key":"key20260804085543_b99-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/jcmm.12811","article-title":"Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells","volume":"20","author":"Hung","year":"2016","journal-title":"J Cell Mol Med"},{"issue":"eade9944","key":"key20260804085543_b100-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9944","article-title":"Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response","volume":"9","author":"Lin","year":"2023","journal-title":"Sci Adv"},{"key":"key20260804085543_b101-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.semcancer.2020.04.006","article-title":"Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics","volume":"68","author":"Kirtonia","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"780200","key":"key20260804085543_b102-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.780200","article-title":"Metformin Combining PD-1 inhibitor enhanced Anti-tumor efficacy in STK11 mutant lung cancer through AXIN-1-dependent inhibition of STING ubiquitination","volume":"9","author":"Wang","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"12632","key":"key20260804085543_b103-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12632","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"issue":"155825","key":"key20260804085543_b104-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155825","article-title":"Centipeda minima and 6-O-angeloylplenolin enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancer","volume":"132","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"91","key":"key20260804085543_b105-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00552-0","article-title":"Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets","volume":"13","author":"Hong","year":"2024","journal-title":"Exp Hematol Oncol"},{"issue":"4066","key":"key20260804085543_b106-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39920-5","article-title":"ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"issue":"e148274","key":"key20260804085543_b107-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148274","article-title":"The abscopal effect: A sense of DNA damage is in the air","volume":"131","author":"Lippert","year":"2021","journal-title":"J Clin Invest"},{"key":"key20260804085543_b108-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic-a new approach to cancer therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"1579","key":"key20260804085543_b109-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061579","article-title":"Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics","volume":"12","author":"Antao","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"46","key":"key20260804085543_b110-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-022-00112-0","article-title":"An overview of PROTACs: A promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Mol Biomed"},{"issue":"259","key":"key20260804085543_b111-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01633-7","article-title":"Deubiquitinating enzymes: Potential regulators of the tumor microenvironment and implications for immune evasion","volume":"22","author":"Hsu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"key20260804085543_b112-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ame2.12165","article-title":"Cancer models in preclinical research: A chronicle review of advancement in effective cancer research","volume":"4","author":"Sajjad","year":"2021","journal-title":"Animal Model Exp Med"},{"issue":"1164535","key":"key20260804085543_b113-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1164535","article-title":"Tumor heterogeneity: Preclinical models, emerging technologies, and future applications","volume":"13","author":"Proietto","year":"2023","journal-title":"Front Oncol"},{"issue":"1786943","key":"key20260804085543_b114-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1786943","article-title":"Editorial: Ubiquitination in tumor pathogenesis and progression and its therapeutic potential","volume":"17","author":"Dar","year":"2026","journal-title":"Front Immunol"},{"key":"key20260804085543_b115-ETM-32-3-13243","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.gendis.2022.01.002","article-title":"Emerging role of ubiquitination\/deubiquitination modification of PD-1\/PD-L1 in cancer immunotherapy","volume":"10","author":"Ding","year":"2023","journal-title":"Genes Dis"},{"issue":"1722559","key":"key20260804085543_b116-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1722559","article-title":"The ubiquitination-autophagy axis in cancer therapy resistance: Mechanistic insights and therapeutic opportunities","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1707","key":"key20260804085543_b117-ETM-32-3-13243","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03545-5","article-title":"Pan-cancer multi-omics profiling reveals ubiquitin D as a novel biomarker for diagnosis, immune microenvironment remodeling and prognostic prediction","volume":"16","author":"Su","year":"2025","journal-title":"Discov Oncol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:55:50Z","timestamp":1785822950000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":117,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,15]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13243","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}